Apr 09, 2020 / 12:00PM GMT
Operator
Ladies and gentlemen, good morning. I'd like to welcome everyone to Theravance Biopharma conference call. (Operator Instructions) Today's conference is being recorded.
And now I would like to turn the call over to Gail Cohen, Vice President, Corporate Communications. Please go ahead.
Gail B. Cohen - Theravance Biopharma, Inc. - VP of Corporate Communications & IR
Good morning, everyone. And thank you for joining our conference call and webcast. Joining us are Rick Winningham, Chief Executive Officer; Brett Haumann; Chief Medical Officer; and Phillip Worboys, Senior Vice President, Research and Translational Science. Following some prepared remarks, we will open the call for questions. A copy of the press release and the slides accompanying this call can be downloaded from our website, or you can call Investor Relations at (650) 808-4045, and we'll be happy to assist you.
As always, I remind you that this conference call will contain forward-looking statements, which involve certain risks and uncertainties, including statements about our
Theravance Biopharma, Inc. - Special Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers